Linuo Pharmaceutical Packaging Co., Ltd.
力诺药包
301188
Shenzhen Stock Exchange
Key Financials
Announcements
Zhonglun Law Firm in Beijing Legal Opinion on the 2025 Annual General Meeting of Shandong Linuo Pharmaceutical Packaging Co., Ltd.
Announcement of the 2025 Annual General Meeting Resolutions
Pre-disclosure Announcement on the Shareholder's Share Reduction Plan
Guolian Minsheng Securities' Summary Report on the Issuance of Convertible Bonds to Unspecified Objects by Shandong Linuo Pharmaceutical Packaging Co., Ltd.
Guolian Minsheng Securities' Special Verification Report on the Use of Raised Funds by Shandong Linuo Pharmaceutical Packaging Co., Ltd. for 2025
Announcement on the Reappointment of Accounting Firms
Guolian Minsheng Securities' Continuous Supervision Tracking Report on Shandong Linuo Pharmaceutical Packaging Co., Ltd. for 2025
Independent Director Work Report for 2025 (Pan Guangcheng)
Independent Director Work Report for 2025 (Liu Yuan)
Independent Director Work Report for 2025 (Yang Gongsui)
Announcement on Holding the 2025 Performance Briefing
Sustainability Report for the Year 2025
Verification Opinions from Guolian Minsheng Securities on the Internal Control Evaluation Report of Shandong Linuo Pharmaceutical Packaging Co., Ltd. for 2025
Linuo Pharmaceutical Packaging's Internal Control Audit Report for 2025
Internal Control Evaluation Report for the Year 2025
Articles of Association of Shandong Linuo Pharmaceutical Packaging Co., Ltd.
Financial Settlement Report for the Year 2025
Announcement on Applying for Comprehensive Credit Limits from Banks
Announcement on Confirming the Compensation Plans for Directors and Senior Management for 2025 and 2026
Announcement on Changes in Accounting Policies
Announcement on Changing the Company's Registered Capital and Revising the Articles of Association
Announcement on Increasing the Estimated Amount of Daily Related Transactions for 2026
Notice of the 2025 Annual Shareholders' Meeting
Resolution Announcement of the 21st Meeting of the Fourth Board of Directors
Review Opinions of the Independent Directors of the Fourth Board at the Third Special Meeting in 2026
Board of Directors Work Report for the Year 2025
Announcement on the Profit Distribution Plan for the Year 2025
Q1 2026 Report
Special Report on the Storage and Use of Funds Raised in 2025
Verification Report on the Annual Storage, Management, and Use of Funds Raised by Linuo Pharmaceutical Packaging for 2025
Evaluation Report on the Performance of the Accounting Firm for 2025 and the Board of Directors' Audit Committee Report on the Accounting Firm's Supervision Responsibilities
Special Audit Explanation on Non-Operating Fund Occupation and Other Related Fund Transactions
Summary Table of Non-Operating Fund Occupation and Other Related Fund Transactions
Board of Directors' Special Opinion on the Self-Examination of Independent Directors' Independence
2025 Annual Audit Report
2025 Annual Report
2025 Annual Report Summary
Legal Opinion from Zhonglun Law Firm on the Invalidated Restricted Stocks of the 2024 Restricted Stock Incentive Plan of Shandong Linuo Pharmaceutical Packaging Co., Ltd.
Announcement on Invalidating Certain Granted but Unvested Restricted Stocks of the 2024 Restricted Stock Incentive Plan
Announcement on Requesting Shareholders' Meeting Authorization for the Board of Directors to Handle Matters Related to Issuing Stocks to Specific Objects by Simplified Procedures
Verification report by Industrial Securities Co., Ltd. on the inquiry transfer of shares by shareholders of Shandong Linuo Pharmaceutical Packaging Co., Ltd. to specific institutional investors
Report on the results of the inquiry transfer by shareholders of Shandong Linuo Pharmaceutical Packaging Co., Ltd. and the reminder announcement on the change of rights of controlling shareholders reaching an integer multiple of 1%
Announcement on abnormal fluctuations in stock trading
Reminder Announcement on Shareholder Inquiry Transfer Pricing
Industrial Securities Co., Ltd. on the verification opinions regarding the qualifications of shareholders of Shandong Linuo Medical Packaging Co., Ltd. to transfer shares to specific institutional investors
Shareholder Inquiry Transfer Plan of Shandong Linuo Pharmaceutical Packaging Co., Ltd.
Announcement on the Completion of Business Change Registration and Reissuance of Business License for Wholly-Owned Subsidiaries
United Credit Ratings Co., Ltd. Announcement on Terminating the Credit Rating of Shandong Linuo Pharmaceutical Packaging Co., Ltd. and Related Debt Items
Announcement on the Redemption Results of Linuo Convertible Bonds
Announcement on the Delisting of Linuo Convertible Bonds
Announcement on Granting Restricted Stock to Incentive Objects of the Company's 2026 Restricted Stock Incentive Plan
Guolian Minsheng Securities Underwriting and Sponsorship Co., Ltd. Verification Opinion on Shandong Linuo Pharmaceutical Packaging Co., Ltd. using acceptance bills, letters of credit, etc., to pay for funds required for fundraising projects and replacing them with an equivalent amount of raised funds
Announcement on using acceptance bills, letters of credit, etc., to pay for funds required for fundraising projects and replacing them with an equivalent amount of raised funds
Verification Opinion of the Board of Directors' Remuneration and Assessment Committee on Matters Related to the Grant of the Company's 2026 Restricted Stock Incentive Plan
Resolution Announcement of the Twentieth Meeting of the Fourth Board of Directors
Beijing Zhonglun Law Firm Legal Opinion on Matters Related to the Grant of the Company's 2026 Restricted Stock Incentive Plan
Review Opinion of the Second Special Meeting of Independent Directors of the Fourth Board of Directors in 2026
List of Incentive Recipients for the 2026 Restricted Stock Incentive Plan (Grant Date)
Beijing Zhonglun Law Firm's Legal Opinion on Shandong Linuo Pharmaceutical Packaging Co., Ltd.'s Second Extraordinary General Meeting of Shareholders in 2026
Resolutions Announcement of the Second Extraordinary General Meeting of Shareholders in 2026
Announcement on the Release of Partial Share Pledge by the Controlling Shareholder
Important Reminder Announcement Regarding Linuo Convertible Bonds Soon Ceasing Conversion and the Last Half Trading Day Before Redemption
Important Reminder Announcement on the Imminent Suspension of Conversion and the Last Trading Day Before Redemption of Linuo Convertible Bonds
Guolian Minsheng Securities Underwriting and Sponsorship Co., Ltd. Report on the 2025 Continuing Supervision Training for Shandong Linuo Pharmaceutical Packaging Co., Ltd.
Guolian Minsheng Securities Underwriting and Sponsorship Co., Ltd. Report on the 2025 Regular On-site Inspection of Shandong Linuo Pharmaceutical Packaging Co., Ltd.
Important Prompt Announcement on Early Redemption of Linuo Convertible Bonds and Imminent Suspension of Conversion
Self-Inspection Report on Trading of Company Shares by Insiders of the Company's 2026 Restricted Stock Incentive Plan
Verification Opinion and Disclosure Status Explanation of the Board of Directors' Remuneration and Assessment Committee on the List of Initially Granted Incentive Objects for the Company's 2026 Restricted Stock Incentive Plan
Announcement on the Passive Dilution of the Company's Controlling Shareholder's Shareholding Ratio Reaching an Integer Multiple of 1%
Important Notice on Early Redemption of Linuo Convertible Bonds and Imminent Cessation of Conversion
Notice of Changes in Equity Due to Passive Dilution of Shareholding Ratio of Shareholders Holding a Total of 5% or More, Reaching a Multiple of 5% and Falling Below 5%
Simplified Report on Changes in Equity (Fosun Weisheng and its Concerted Party Fosun Weiying)
Important Reminder Announcement Regarding the Imminent Suspension of Trading of Linuo Convertible Bonds and the Last Half Trading Day
Important Reminder Announcement on Early Redemption of Linuo Convertible Bonds and Imminent Suspension of Trading
Important Reminder Announcement Regarding Early Redemption of Linuo Convertible Bonds and Imminent Cessation of Trading
Important Indicative Announcement on Early Redemption of Linuo Convertible Bonds and Imminent Suspension of Trading
Eighth Indicative Announcement on Early Redemption of Linuo Convertible Bonds
Announcement on Linuo Convertible Bonds' Conversion Amount Cumulatively Reaching 10% of the Company's Total Issued Shares Before Conversion
Indicative Announcement on Changes in Equity Due to Passive Dilution of Controlling Shareholder's Shareholding Reaching a Multiple of 5%
Simplified Report on Changes in Equity (Linuo Investment)
"Seventh reminder announcement on the early redemption of Linuo Convertible Bonds",
"Announcement on the progress of matters related to other risk warnings implemented on the company's stock",
Announcement on the Sixth Reminder of Early Redemption of Linuo Convertible Bonds
Notice of Convening the Second Extraordinary General Meeting of Shareholders in 2026
Announcement of Resolutions of the Nineteenth Meeting of the Fourth Board of Directors
Legal Opinion from Beijing Zhonglun Law Firm on the Company's 2026 Restricted Stock Incentive Plan
Verification Opinion of the Board's Remuneration and Assessment Committee on Matters Related to the Company's 2026 Restricted Stock Incentive Plan
GEM Listed Company Equity Incentive Plan Self-Inspection Form
2026 Restricted Stock Incentive Plan Implementation and Assessment Management Measures
2026 Restricted Stock Incentive Plan (Draft)
Summary of the 2026 Restricted Stock Incentive Plan (Draft)
Fifth Reminder Announcement on Early Redemption of Linuo Convertible Bonds
Fourth Indicative Announcement on the Early Redemption of Linuo Convertible Bonds
Announcement on the Passive Dilution of the Controlling Shareholder's Shareholding Ratio Reaching an Integer Multiple of 1%
Third Reminder Announcement on Early Redemption of Linuo Convertible Bonds
Notes & Comments
Sign in to leave a comment or private note.
Loading…